Retracted: Mechanisms and effects of curcumin on spatial learning and memory improvement in APPswe/PS1dE9 mice

Spatial localization does not require the presence of local cues

Morris, R. G. M. (1981) · Learning and Motivation · doi:10.1016/0023-9690(81)90020-5 · Cited by 2,699 · see citing works

Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury

McKee, A. C., Cantu, R. C., Nowinski, C. J., Hedley-Whyte, E. T., Gavett, B. E., Budson, A. E., Santini, V. E., Lee, H.-S., Kubilus, C. A., & Stern, R. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a9d503 · Cited by 2,295 · see citing works

Aβ Oligomers – a decade of discovery

Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938 · see citing works

Curcumin: From ancient medicine to current clinical trials

Hatcher, H., Planalp, R. P., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,847 · see citing works

Role of Genes and Environments for Explaining Alzheimer Disease

Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798 · see citing works

Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase

Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575 · see citing works

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease

Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.017 · Cited by 744 · see citing works

The Targets of Curcumin

Zhou, H., Beevers, C. S., & Huang, S. (2011) · Current Drug Targets · doi:10.2174/138945011794815356 · Cited by 715 · see citing works

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer’s disease

Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686 · see citing works

Curcumin labels amyloid pathology in vivo , disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model

Garcı́a-Alloza, M., Borrelli, L. A., Rozkalne, A., Hyman, B. T., & Bacskai, B. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04613.x · Cited by 663 · see citing works

Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease

Ho, L., Qin, W., Pompl, P., Xiang, Z.-M., Wang, J., Zhao, Z., Peng, Y., Cambareri, G., Rocher, A., Mobbs, C., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0978fje · Cited by 646 · see citing works

Cerebral amyloid angiopathy in the elderly

Viswanathan, A., & Greenberg, S. M. (2011) · Annals of Neurology · doi:10.1002/ana.22516 · Cited by 643 · see citing works

Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone

Watson, G. S., Cholerton, B. A., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Fishel, M. A., Kulstad, J. J., Green, P. S., Cook, D. G., et al. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 607 · see citing works

Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease

Baum, L., Lam, C. W. K., Cheung, S. K. K., Kwok, T. C. Y., Lui, V. W.-C., Tsoh, J., LAM, L. C. W., Leung, V., Hui, E., Ng, C., et al. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160862c · Cited by 594 · see citing works

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

Ringman, J. M., Frautschy, S. A., Teng, E., Begum, A. N., Bardens, J., Beigi, M., Gylys, K. H., Badmaev, V., Heath, D. D., Apostolova, L. G., et al. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt146 · Cited by 546 · see citing works

A Potential Role of the Curry Spice Curcumin in Alzheimers Disease

Ringman, J. M., Frautschy, S. A., Cole, G. M., Masterman, D. L., & Cummings, J. L. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585882 · Cited by 519 · see citing works

Impaired spatial and sequential learning in rats treated neonatally with d ‐fenfluramine

Morford, L. L., Inman-Wood, S. L., Gudelsky, G. A., Williams, M. T., & Vorhees, C. V. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02100.x · Cited by 454 · see citing works

REVIEW: Curcumin and Alzheimer’s disease

Hamaguchi, T., Ono, K., & Yamada, M. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00147.x · Cited by 450 · see citing works

The Role of Insulin Resistance in the Pathogenesis of Alzheimer??s Disease

Watson, G. S., & Craft, S. (2003) · CNS Drugs · doi:10.2165/00023210-200317010-00003 · Cited by 396 · see citing works

Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study

Gold, M., Alderton, C., Zvartau-Hind, M., Egginton, S., Saunders, A. M., Irizarry, M., Craft, S., Landreth, G., Linnamägi, Ü., & Sawchak, S. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000318845 · Cited by 361 · see citing works

Exercise, inflammation and aging.

(2012) · Europe PMC (PubMed Central) · Cited by 345 · see citing works

Apolipoprotein E Polymorphism and Alzheimer Disease

Ganguli, M., Chandra, V., Kamboh, M. I., Johnston, J. M., Dodge, H. H., Thelma, B. K., Juyal, R. C., Pandav, R. S., Belle, S. H., & DeKosky, S. T. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.824 · Cited by 337 · see citing works

Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice

Pedersen, W. A., McMillan, P. J., Kulstad, J. J., Leverenz, J. B., Craft, S., & Haynatzki, G. R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.018 · Cited by 321 · see citing works

Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer’s disease

Ahmed, T., & Gilani, A.-H. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.09.010 · Cited by 301 · see citing works

Incidence of Alzheimer’s disease in a rural community in India

Chandra, V., Pandav, R. S., Dodge, H. H., Johnston, J. M., Belle, S. H., DeKosky, S. T., & Ganguli, M. (2001) · Neurology · doi:10.1212/wnl.57.6.985 · Cited by 283 · see citing works

Aβ-degrading enzymes: potential for treatment of Alzheimer disease

Miners, J. S., Barua, N., Kehoe, P. G., Gill, S., & Love, S. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182345e46 · Cited by 265 · see citing works

Early-Life Risk Factors for Alzheimer Disease

Borenstein, A. R., Copenhaver, C. I., & Mortimer, J. A. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000201854.62116.d7 · Cited by 259 · see citing works

Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm

Lal, R., Lin, H., & Quist, A. P. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.04.021 · Cited by 203 · see citing works

Curcumin Decreases Amyloid-β Peptide Levels by Attenuating the Maturation of Amyloid-β Precursor Protein

Zhang, C. M., Browne, A., Child, D. D., & Tanzi, R. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133520 · Cited by 190 · see citing works

Curcumin and neurodegenerative diseases: a perspective

Darvesh, A. S., Carroll, R. T., Bishayee, A., Novotny, N. A., Geldenhuys, W. J., & der Schyf, C. J. V. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.693479 · Cited by 189 · see citing works

Identification of Distinct γ-Secretase Complexes with Different APH-1 Variants

Shirotani, K., Edbauer, D., Prokop, S., Haass, C., & Steiner, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405768200 · Cited by 173 · see citing works

Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues

Wei, Q., Chen, W., Zhou, B., Li, Y., & Liu, Z. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.09.008 · Cited by 172 · see citing works

Curcumin effects on blood lipid profile in a 6-month human study

Baum, L., Cheung, S. K. K., Mok, V., Lam, L. C. W., Leung, V., Hui, E., Ng, C., Chow, M., Ho, P. C., & Lam, S. S. L. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.013 · Cited by 142 · see citing works

Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer’s disease mouse model

Escribano, L., Simón, A., Pérez‐Mediavilla, A., Colocho, P. E. S., Río, J. D., & Frechilla, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.071 · Cited by 135 · see citing works

Inflammation in aging: cause, effect, or both?

Jenny, N. S. (2012) · PubMed · Cited by 130 · see citing works

Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer’s disease

Zhang, X., Hongmei, Z., Lu, S. Q., & Li, Y. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70629-6 · Cited by 116 · see citing works

Pleiotropic Protective Effects of Phytochemicals in Alzheimer's Disease

Davinelli, S., Sapere, N., Zella, D., Bracale, R., Intrieri, M., & Scapagnini, G. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/386527 · Cited by 111 · see citing works

Natural Products As A Rich Source Of Tau-Targeting Drugs For Alzheimer’s Disease

Calcul, L., Zhang, B., Jinwal, U. K., Dickey, C. A., & Baker, B. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.124 · Cited by 107 · see citing works

Cardiovascular protection by curcumin: molecular aspects.

Kapakos, G., Youreva, V., & Srivastava, A. K. (2012) · PubMed · Cited by 89 · see citing works

Acetylcholine esterase activity in mild cognitive impairment and Alzheimer’s disease

Herholz, K. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0699-4 · Cited by 87 · see citing works

Curcuminoid Binds to Amyloid-β1-42 Oligomer and Fibril

Yanagisawa, D., Taguchi, H., Yamamoto, A., Shirai, N., Hirao, K., & Tooyama, I. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102100 · Cited by 85 · see citing works

A review of genome mutation and Alzheimer's disease

Thomas, P., & Fenech, M. F. (2006) · Mutagenesis · doi:10.1093/mutage/gel055 · Cited by 85 · see citing works

<scp>S</scp>t.<scp>J</scp>ohn's<scp>W</scp>ort Reduces Beta‐Amyloid Accumulation in a Double Transgenic<scp>A</scp>lzheimer's Disease Mouse Model—Role of<scp>P</scp>‐Glycoprotein

Brenn, A., Grube, M., Jedlitschky, G., Fischer, A., Strohmeier, B., Eiden, M., Keller, M., Groschup, M. H., & Vogelgesang, S. (2014) · Brain Pathology · doi:10.1111/bpa.12069 · Cited by 79 · see citing works

Advances in Clinical Study of Curcumin

Yang, C., Su, X. J., Liu, A., Zhang, L., Yu, A., Xi, Y., & Zhai, G. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319110002 · Cited by 69 · see citing works

Pathological activity of familial Alzheimer’s disease-associated mutant presenilin can be executed by six different γ-secretase complexes

Shirotani, K., Tomioka, M., Kremmer, E., Haass, C., & Steiner, H. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.011 · Cited by 68 · see citing works

Noninvasive Magnetic Resonance Imaging Detection of Cerebral Amyloid Angiopathy-Related Microvascular Alterations Using Superparamagnetic Iron Oxide Particles in APP Transgenic Mouse Models of Alzheimer's Disease: Application to Passive Aβ Immunotherapy

Beckmann, N., Gérard, C., Abramowski, D., Cannet, C., & Staufenbiel, M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4936-10.2011 · Cited by 65 · see citing works

Pen2 and Presenilin-1 Modulate the Dynamic Equilibrium of Presenilin-1 and Presenilin-2 γ-Secretase Complexes

Placanica, L., Tarassishin, L., Yang, G., Peethumnongsin, E., Kim, S., Zheng, H., Sisodia, S. S., & Li, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807269200 · Cited by 60 · see citing works

Rosiglitazone Improves Spatial Memory and Decreases Insoluble Aβ1–42 in APP/PS1 Mice

O’Reilly, J.-A., & Lynch, M. A. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9282-7 · Cited by 56 · see citing works

Secretases as targets for the treatment of Alzheimer’s disease

Citron, M. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01759-7 · Cited by 44 · see citing works

Activation of α-secretase by curcumin-aminoacid conjugates

Narasingapa, R. B., Jargaval, M. R., Srinivas, P., Htoo, H. H., Rao, K. S. J., Hernandez, J., Govitrapong, P., & Vincent, B. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.010 · Cited by 41 · see citing works

The effects of MyD88 deficiency on exploratory activity, anxiety, motor coordination, and spatial learning in C57BL/6 and APPswe/PS1dE9 mice

Lim, J. E., Song, M., Jin, J., Kou, J., Pattanayak, A., Lalonde, R., & Fukuchi, K. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.027 · Cited by 34 · see citing works

Differential effects of γ‐secretase and BACE1 inhibition on brain Aβ levels in vitro and in vivo

Elvang, A. B., Volbracht, C., Pedersen, L. Ø., Jensen, K. G., Karlsson, J.-J., Larsen, S. A., Mørk, A., Stensbøl, T. B., & Bastlund, J. F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06215.x · Cited by 26 · see citing works

Immunohistochemical visualization of neurons and specific glial cells for stereological application in the porcine neocortex

Lyck, L., Jelsing, J., Jensen, P. S., Lambertsen, K. L., Pakkenberg, B., & Finsen, B. R. (2005) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2005.09.009 · Cited by 24 · see citing works

Turmeric and curcumin suppress presenilin 1 protein expression in Jurkat cells

Yoshida, H., Okumura, N., Nishimura, Y., Kitagishi, Y., & Matsuda, S. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.246 · Cited by 18 · see citing works

The n-terminal 5-MER peptide analogue P165 of amyloid precursor protein exerts protective effects on SH-SY5Y cells and rat hippocampus neuronal synapses

Wang, P., Jiang, S. J. Y. G., Cui, Y. B., Yue, Z., Su, C., Sun, J., Sheng, S., & Tian, J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.069 · Cited by 18 · see citing works

Cellular and molecular mechanisms of curcumin in prevention and treatment of disease

Patel, S. S., Acharya, A., Ray, R. S., Agrawal, R. K., Raghuwanshi, R., & Jain, P. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1552244 · Cited by 518 · see citing works

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease

Yarza, R., Vela, S., Solas, M., & Ramírez, M. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00321 · Cited by 418 · see citing works

Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer’s Disease

Reddy, P. H., Manczak, M., Yin, X., Grady, M. C., Mitchell, A., Tonk, S., Kuruva, C. S., Bhatti, J. S., Kandimalla, R., Vijayan, M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170512 · Cited by 354 · see citing works

Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial

Small, G. W., Siddarth, P., Li, Z., Miller, K. J., Ercoli, L. M., Emerson, N. D., Martinez, J., Wong, K. P., Liu, J., Merrill, D. A., et al. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.10.010 · Cited by 357 · see citing works

Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies

Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092313 · Cited by 240 · see citing works

Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?

Liddell, J. R. (2017) · Antioxidants · doi:10.3390/antiox6030065 · Cited by 167 · see citing works

Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer’s disease and multiple sclerosis

Srinivasan, M., & Lahiri, D. K. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.989834 · Cited by 164 · see citing works

Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs

Tewari, D., Stankiewicz, A. M., Mocan, A., Sah, A. N., Tzvetkov, N. T., Huminiecki, Ł., Horbańczuk, J. O., & Atanasov, A. G. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00003 · Cited by 136 · see citing works

Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease

Sharma, C., & Kim, S. R. (2021) · Antioxidants · doi:10.3390/antiox10081231 · Cited by 136 · see citing works

Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer’s disease?

Pivovarova‐Ramich, O., Höhn, A., Grune, T., Pfeiffer, A. F. H., & Rudovich, N. N. (2016) · Annals of Medicine · doi:10.1080/07853890.2016.1197416 · Cited by 132 · see citing works

Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer’s Disease: Impacts on Cognitive Decline

Walker, J., & Harrison, F. E. (2015) · Nutrients · doi:10.3390/nu7095341 · Cited by 127 · see citing works

Barth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell Studies

Šarić, A., Andréau, K., Armand, A., Møller, I. M., & Petit, P. X. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2015.00359 · Cited by 114 · see citing works

Efficacy of curcumin for age-associated cognitive decline: a narrative review of preclinical and clinical studies

Sarker, M. R., & Franks, S. F. (2018) · GeroScience · doi:10.1007/s11357-018-0017-z · Cited by 108 · see citing works

Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview

Libro, R., Giacoppo, S., Soundara Rajan, T., Bramanti, P., & Mazzon, E. (2016) · Molecules · doi:10.3390/molecules21040518 · Cited by 107 · see citing works

The impact of curcumin and its modified formulations on Alzheimer's disease

Farkhondeh, T., Samarghandian, S., Pourbagher‐Shahri, A. M., & Sedaghat, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28411 · Cited by 109 · see citing works

Curcumin–piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy

Li, Q., Zhai, W.-W., Jiang, Q., Huang, R., Liu, L., Dai, J., Gong, W., Du, S., & Wu, Q. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.05.008 · Cited by 105 · see citing works

Beneficial properties of natural phenols: Highlight on protection against pathological conditions associated with amyloid aggregation

Stefani, M., & Rigacci, S. (2014) · BioFactors · doi:10.1002/biof.1171 · Cited by 105 · see citing works

Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer’s Disease Biology: Characterization of Putative Cognates for Therapeutic Applications

Jha, N. K., Jha, S. K., Kumar, D., Kejriwal, N., Sharma, R., Ambasta, R. K., & Kumar, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150379 · Cited by 88 · see citing works

Brain Glucose Transporters: Role in Pathogenesis and Potential Targets for the Treatment of Alzheimer’s Disease

Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158142 · Cited by 88 · see citing works

Nanotechnology to improve the Alzheimer’s disease therapy with natural compounds

Ramalho, M. J., Andrade, S., Loureiro, J. A., & do Carmo Pereira, M. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-019-00694-3 · Cited by 75 · see citing works

Synergic Effects of Berberine and Curcumin on Improving Cognitive Function in an Alzheimer’s Disease Mouse Model

Lin, L., Cheng, L., Zhang, D., Yuan, M., Chen, C., & Li, M. (2020) · Neurochemical Research · doi:10.1007/s11064-020-02992-6 · Cited by 72 · see citing works

Curcumin, Cardiometabolic Health and Dementia

Kim, Y., & Clifton, P. M. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15102093 · Cited by 67 · see citing works

Brain Food for Alzheimer-Free Ageing: Focus on Herbal Medicines

Hügel, H. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18365-7_5 · Cited by 58 · see citing works

Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer’s Disease: A Systematic Review

da Costa, I. M., Freire, M. A. M., Cavalcanti, J. R. L. D. P., de Araújo, D. P., Norrara, B., Rosa, I. M. M. M., de Azevedo, E. P., do Rêgo, A. C. M., Araújo-Filho, I., & Gúzen, F. P. (2018) · Current Neuropharmacology · doi:10.2174/0929867325666180117112610 · Cited by 56 · see citing works

Curcumin regulates insulin pathways and glucose metabolism in the brains of APPswe/PS1dE9 mice

Wang, P., Su, C., Feng, H., Chen, X., Dong, Y., Rao, Y., Ren, Y., Yang, J.-D., Shi, J., Tian, J., et al. (2017) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632016688025 · Cited by 53 · see citing works

Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives

Ayaz, M., Mosa, O. F., Nawaz, A., Hamdoon, A. A. E., Elkhalifa, M. E. M., Sadiq, A., Ullah, F., Ahmed, A., Kabra, A., Khan, H. Z., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155272 · Cited by 49 · see citing works

Inhalable Curcumin: Offering the Potential for Translation to Imaging and Treatment of Alzheimer's Disease

McClure, R., Yanagisawa, D., Stec, D. F., Abdollahian, D., Koktysh, D. S., Xhillari, D., Jaeger, R. J., Stanwood, G. D., Chekmenev, E. Y., Tooyama, I., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-140798 · Cited by 47 · see citing works

Polyhydroxycurcuminoids but not curcumin upregulate neprilysin and can be applied to the prevention of Alzheimer’s disease

Chen, P., Chen, Z.-T., Hou, W., Yu, L., & Chen, R. P. ‐. (2016) · Scientific Reports · doi:10.1038/srep29760 · Cited by 47 · see citing works

Curcumin-loaded self-nanomicellizing solid dispersion system: part II: in vivo safety and efficacy assessment against behavior deficit in Alzheimer disease

Parikh, A. R., Kathawala, K., Li, J.-T., Chen, C., Shan, Z., Cao, X., Zhou, X., & Garg, S. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0570-0 · Cited by 46 · see citing works

Curcumin ameliorates insulin signalling pathway in brain of Alzheimer’s disease transgenic mice

Feng, H., Dang, H.-Z., Fan, H. J., Chen, X., Rao, Y., Ren, Y., Yang, J.-D., Shi, J., Wang, P., & Tian, J. (2016) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632016659494 · Cited by 42 · see citing works

Effects of curcumin on synapses in APPswe/PS1dE9 mice

He, Y., Wang, P., Wei, P., Feng, H., Ren, Y., Yang, J.-D., Rao, Y., Shi, J., & Tian, J. (2016) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632016638099 · Cited by 38 · see citing works

Curcumin upregulates S100 expression and improves regeneration of the sciatic nerve following its complete amputation in mice

Luo, Y., Liu, G., Xu, K., & Li, J. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.189196 · Cited by 37 · see citing works

Secondary Metabolites from Plants Possessing Inhibitory Properties against Beta-Amyloid Aggregation as Revealed by Thioflavin-T Assay and Correlations with Investigations on Transgenic Mouse Models of Alzheimer's Disease

Stefanescu, R., Stanciu, G. D., Luca, A., Paduraru, L., & Tamba, B.-I. (2020) · Biomolecules · doi:10.3390/biom10060870 · Cited by 35 · see citing works

Curcumin supplementation and motor-cognitive function in healthy middle-aged and older adults

Santos-Parker, J. R., Lubieniecki, K. L., Rossman, M. J., Ark, H. J. V., Bassett, C. J., Strahler, T. R., Chonchol, M., Justice, J., & Seals, D. (2018) · Nutrition and Healthy Aging · doi:10.3233/nha-170029 · Cited by 31 · see citing works

The Effect of Solvent on Tautomerism, Acidity and Radical Stability of Curcumin and Its Derivatives Based on Thermodynamic Quantities

Anjomshoa, S., Namazian, M., & Noorbala, M. R. (2016) · Journal of Solution Chemistry · doi:10.1007/s10953-016-0481-y · Cited by 33 · see citing works

The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment

Zieneldien, T., Kim, J., & Cao, C. (2022) · Geriatrics · doi:10.3390/geriatrics7020024 · Cited by 29 · see citing works

Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

Froestl, W., Pfeifer, A., & Muhs, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121729 · Cited by 27 · see citing works

Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease

Reddy, A. P., & Reddy, P. H. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.010 · Cited by 25 · see citing works

The Additive Effects of Low Dose Intake of Ferulic Acid, Phosphatidylserine and Curcumin, Not Alone, Improve Cognitive Function in APPswe/PS1dE9 Transgenic Mice

Okuda, M., Fujita, Y., & Sugimoto, H. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00332 · Cited by 25 · see citing works

Therapeutic potential of aromatic plant extracts in Alzheimer's disease: Comprehensive review of their underlying mechanisms

Ma, Y., Li, Y., Yin, R., Guo, P., Lei, N., Li, G., Xiong, L., & Xie, Y. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14234 · Cited by 21 · see citing works

New Insights into Epigenetic and Pharmacological Regulation of Amyloid-Degrading Enzymes

Nalivaeva, N. N., Belyaev, N. D., & Turner, A. J. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1703-1 · Cited by 20 · see citing works

The next step of neurogenesis in the context of Alzheimer’s disease

Moradi, H. R., Hajali, V., Khaksar, Z., Vafaee, F., Forouzanfar, F., & Negah, S. S. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06520-9 · Cited by 20 · see citing works

The combination of swimming and curcumin consumption may improve spatial memory recovery after binge ethanol drinking

Feizolahi, F., Azarbayjani, M. A., Nasehi, M., Peeri, M., & Zarrindast, M. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.03.018 · Cited by 14 · see citing works

The effect of three polyphenols and some other antioxidant substances on amyloid fibril formation by Human cystatin C

Jahić, A., Žnidarič, M. T., Pintar, S., Berbić, S., & Žerovnik, E. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104806 · Cited by 13 · see citing works

Lifestyle and Alzheimer’s Disease

Bartolotti, N., & Lazarov, O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00007-3 · Cited by 12 · see citing works

Therapeutic potential of curcumin on the cognitive decline in animal models of Alzheimer’s disease: a systematic review and meta-analysis

Fan, L., & Zhang, Z. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-02946-7 · Cited by 12 · see citing works

Modulators of Amyloid β-Protein (Aβ) Self-Assembly

Rahimi, F., Li, H. J., Sinha, S., & Bitan, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00006-x · Cited by 12 · see citing works

Curcuminoids and Novel Opportunities for the Treatment of Alzheimer's Disease: Which Molecules are Actually Effective?

Zholos, A. V., Moroz, O. F., & Storozhuk, M. (2018) · Current Molecular Pharmacology · doi:10.2174/1874467211666181012150847 · Cited by 12 · see citing works

Natural Compounds as Inhibitors of Aβ Peptide and Tau Aggregation

Monteiro, K. L. C., de Aquino, T. M., & da Silva‐Júnior, E. F. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273273539231114095300 · Cited by 9 · see citing works

The influence of GAPT extraction on synapse loss of APPswe/PS1dE9 transgenic mice via adjusting Bcl‐2/Bax balance

Shi, J., Zhang, X., Ni, J., Wei, M., Li, T., Zhou, B., Liu, X., Zhang, L., Wang, P., Tian, J., et al. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.10.008 · Cited by 8 · see citing works

A novel rhamnoside derivative PL402 up-regulates matrix metalloproteinase 3/9 to promote Aβ degradation and alleviates Alzheimer’s-like pathology

Hu, T., Zhou, Y., Lu, J. N., Xia, P., Chen, Y., Cao, X., & Pei, G. (2020) · Aging · doi:10.18632/aging.102637 · Cited by 8 · see citing works

Curcumin can influence synaptic dysfunction in APPswe/PS1dE9 mice

Chen, F., He, Y., Wang, P., Wei, P., Feng, H., Rao, Y., Shi, J., & Tian, J. (2018) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2018.03.005 · Cited by 7 · see citing works

Potential involvement of oxidative stress in induction of neurodegenerative diseases: Actions, mechanisms and neurotherapeutic potential of natural antioxidants

Oliveira, G. L. D. S., de Oliveira, F. R. D. A. M., & de Freitas, R. M. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.5897/ajpp2013.3963 · Cited by 6 · see citing works

Emerging nano-derived therapy for the treatment of dementia: a comprehensive review

Ahmad, S., Ahmad, L., Adil, M., Sharma, R., khan, S., Hasan, N., & Aqil, M. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01863-3 · Cited by 4 · see citing works

Is the Combination/Multi-target Therapy a New Promise for Alzheimer's Disease?

Zhang, X., & Shi, J. (2016) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000216 · Cited by 4 · see citing works

Potential Neuroprotective Effects of Curcumin against Dementia

Brondino, N., Fusar‐Poli, L., Panisi, C., & Politi, P. (2017) · doi:10.1002/9781119155195.ch22 · Cited by 4 · see citing works

Alzheimer’s Disease Pathogenic Mechanisms: Linking Redox Homeostasis and Mitochondria-Associated Metabolic Pathways Through Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)

Rostagno, A. A., & Ghiso, J. A. (2025) · Antioxidants · doi:10.3390/antiox14070812 · Cited by 2 · see citing works

Targeting Assembly and Disassembly of Protein Aggregates

Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801944-3.00006-0 · Cited by 2 · see citing works

Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases

Kalita, R., Sarma, A., Baruah, H., Zaman, A., & Goswami, D. (2026) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.70021 · Cited by 1 · see citing works

Nutraceuticals Supporting Cognitive Function in Mild Cognitive Impairment

Strilchuk, L. M. (2021) · Contemporary cardiology · doi:10.1007/978-3-030-62632-7_10 · Cited by 1 · see citing works

Summary, Perspective and Direction for Future Research

Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_10

Effects of Curcumin on Oxidative Stress in Animal Models and Patients with Alzheimer Disease

Farooqui, A. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-15889-1_6

Secondary Prevention of Alzheimer’s Disease

Friel, H., & Frautschy, S. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812259-4.00004-7

Mapping a Link Between Mercury Toxicity and Alzheimer’s Disease

Kundu, S. (2021) · Springer eBooks · doi:10.1007/978-981-16-4558-7_5

Effect of Curcumin on Production and Degradation of Aβ in APPswe/PS1dE9 Double Transgenic Mice

Jian-ning, S. (2010) · Acta Laboratorium Animalis Scientia Sinica

Effect of curcumin on expression of Aβ42 and Aβ-degrading enzyme NEP in APPswe/PS1dE9 double transgenic mice

Pengwen, W. (2011) · China Journal of Chinese Materia Medica · doi:10.4268/cjcmm20110830 · Cited by 1 · see citing works

Curcumin Ameliorates Memory Decline via Inhibiting BACE1 Expression and β-Amyloid Pathology in 5×FAD Transgenic Mice

Zheng, K.-M., Dai, X., Xiao, N., Wu, X., Wei, Z., Fang, W., Zhu, Y., Zhang, J., & Chen, X. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9802-9 · Cited by 96 · see citing works

P4‐166: Effects of novel curcumin derivative with C‐4 substituent on cognitive impairment and amyloid deposition in APPswe/PS1dE9 mice

Yanagisawa, D., Ibrahim, N. F., Durani, L. W., Hamezah, H. S., Taguchi, H., Morikawa, S., Hirao, K., Shirai, N., & Tooyama, I. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.1873

Neuroprotective effect of curcumin to Aβ of double transgenic mice with Alzheimer’s disease

Feng, H., Fan, H., Dang, H.-Z., Chen, X., Ren, Y., Yang, J.-D., & Wang, P. (2014) · China Journal of Chinese Materia Medica · doi:10.4268/cjcmm20141936 · Cited by 14 · see citing works